Home › Hemoglobinopathies
Hemoglobinopathies clinical trials recruiting in the U.S.
14 studies for Hemoglobinopathies are recruiting participants at sites across the United States.
Cities with the most studies
- St. Louis, MO4 studies
- New York City, NY4 studies
- Philadelphia, PA3 studies
- Nashville, TN3 studies
- Memphis, TN3 studies
- Minneapolis, MN3 studies
By state
Recently updated studies
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
RecruitingEarly phase 1
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06313398Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
RecruitingPhase 1/2
Up to age 20 · All sexes · Updated Sep 16, 2026 · NCT00920972Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy
RecruitingObservational study
All ages · All sexes · Updated Sep 15, 2026 · NCT06646640The HOPE Biobank Resource (BMT CTN 2402 HOPE)
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Aug 27, 2026 · NCT07227155Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Recruiting
Up to age 55 · All sexes · Updated Jul 6, 2026 · NCT01666080TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
RecruitingPhase 2
Ages 0 to 21 · All sexes · Updated Jul 1, 2026 · NCT04356469Allo HSCT for High Risk Hemoglobinopathies
RecruitingPhase 2Healthy volunteers welcome
Up to age 55 · All sexes · Updated Jun 4, 2026 · NCT06872333Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
RecruitingPhase 1/2
1 Day – 21 Years · All sexes · Updated May 29, 2026 · NCT03128996Discarded Bone Marrow for Hematology Research
RecruitingObservational study
All ages · All sexes · Updated May 5, 2026 · NCT04671212Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
RecruitingPhase 1/2
1 Month – 25 Years · All sexes · Updated Apr 15, 2026 · NCT06839456Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RecruitingPhase 3
Ages 12 to 35 · All sexes · Updated Mar 23, 2026 · NCT05477563Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
RecruitingPhase 2
Up to age 21 · All sexes · Updated Mar 13, 2026 · NCT04644016A Long-term Follow-up Study in Patients Who Received BEAM-101
RecruitingObservational study
Ages 14 to 37 · All sexes · Updated Jan 28, 2026 · NCT07373639Study of the Role of Genetic Modifiers in Hemoglobinopathies
RecruitingObservational study
Ages 2 and older · All sexes · Updated Mar 20, 2024 · NCT05799118From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.